GRTS
Gritstone Oncology Inc
NASDAQ: GRTS · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-30
Market cap
$3.80M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
—
Gritstone Oncology Inc (GRTS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+14.5%
Last 4 quarters
Revenue YoY growth
-85.8%
Most recent quarter
EPS YoY growth
+48.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-06-30 | $-0.28 | $-0.16 | +42.9% | $57000.00 | -85.8% |
| 2024-03-31 | $-0.32 | $-0.34 | -6.3% | $49000.00 | -91.0% |
| 2023-12-31 | $-0.33 | $-0.26 | +21.2% | $29000.00 | -97.8% |
| 2023-09-30 | $-0.33 | $-0.33 | +0.0% | $1.56M | +258.9% |
| 2023-06-30 | $-0.35 | $-0.31 | +11.4% | $400000.00 | -85.5% |
| 2023-03-31 | $-0.33 | $-0.30 | +9.1% | $542000.00 | -88.6% |
| 2022-12-31 | $-0.34 | $-0.30 | +11.8% | $1.33M | -25.4% |
| 2022-09-30 | $-0.40 | $-0.35 | +12.5% | $436000.00 | -81.8% |
| 2022-06-30 | $-0.40 | $-0.34 | +15.0% | $2.76M | — |
| 2022-03-31 | $-0.37 | $-0.34 | +8.1% | $4.75M | — |
| 2021-12-31 | $-0.38 | $-0.37 | +2.6% | $1.78M | — |
| 2021-09-30 | $-0.52 | $-0.36 | +30.8% | $2.40M | — |
Frequently asked questions
Has Gritstone Oncology Inc beaten earnings estimates?
Gritstone Oncology Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +14.5% over the last 4 quarters.
What is Gritstone Oncology Inc's revenue growth rate?
Gritstone Oncology Inc reported year-over-year revenue growth of -85.8% in its most recent quarter, with EPS growing +48.4% year-over-year.